| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/14/2013 | US20130040935 Cyclic keto-enols for therapy |
| 02/14/2013 | US20130039904 Gambogic acid cyclization analogues, their preparation method and application thereof |
| 02/14/2013 | CA2842885A1 Quinazoline-2,4-dione derivatives |
| 02/13/2013 | EP2556073A1 Bicyclic pyrimidinyl pyrazoles |
| 02/13/2013 | CN102933586A Nitroimidazole derivatives |
| 02/13/2013 | CN102933565A Cyclic carbodiimide compound |
| 02/13/2013 | CN102933542A Process for production of intermediate for cyclic carbodiimide compound |
| 02/13/2013 | CN102925511A Staurosporine preparation method |
| 02/13/2013 | CN102924479A Semisynthetic method of staurosporine derivative |
| 02/13/2013 | CN102924478A Preparing method of compound FK506-A |
| 02/13/2013 | CN102924477A New oxazine compound and application thereof |
| 02/13/2013 | CN102924476A Novel oxazine compounds and application thereof |
| 02/13/2013 | CN102924475A Novel oxazine compound and use of oxazine compound for anti-platelet aggregation |
| 02/13/2013 | CN102161664B Photoreaction-based synthesis method of spiro isoquinoline polycyclic heterocyclic compounds |
| 02/13/2013 | CN102020662B Method for preparing torisel |
| 02/13/2013 | CN102020661B Method for synthesizing torisel |
| 02/12/2013 | US8372985 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates |
| 02/12/2013 | US8372823 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/07/2013 | WO2013018928A1 Fused heterocyclic compound and use thereof for pest control |
| 02/07/2013 | US20130035754 Drug-delivery endovascular stent and method of forming the same |
| 02/07/2013 | US20130035483 Methods of converting amorphous drug substance into crystalline form |
| 02/07/2013 | US20130035341 Macrocyclic integrase inhibitors |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | CA2844241A1 Fused heterocyclic compound and use thereof for pest control |
| 02/06/2013 | EP2552923A1 Macrocyclic integrase inhibitors |
| 02/06/2013 | EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 02/06/2013 | CN1938298B Methods for minimizing thioamide impurities |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/05/2013 | US8367822 Compositions and methods for bone formation and remodeling |
| 02/05/2013 | US8367659 Oxazinyl isoflavonoid compounds, medicaments and use |
| 02/05/2013 | CA2558899C Fused ring azadecalin glucocorticoid receptor modulators |
| 02/05/2013 | CA2508792C Heterocyclic compounds, methods of making them and their use in therapy |
| 01/31/2013 | WO2013015984A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030027 Hemi-phorboxazole a derivatives and methods of their use |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | US20130028872 Composition and method for differentiation of human embryonic stem cells |
| 01/31/2013 | CA2843245A1 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
| 01/30/2013 | EP2549870A1 Process for preparing carbamoylpyridone derivatives and intermediates |
| 01/30/2013 | CN102906099A (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants |
| 01/30/2013 | CN102906098A Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 01/29/2013 | US8362011 Tricyclic triazolic compounds |
| 01/29/2013 | CA2658190C Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2013 | WO2013012500A1 Trpv4 antagonists |
| 01/24/2013 | WO2013010904A1 Novel substituted indole derivatives as gamma secretase modulators |
| 01/24/2013 | WO2012010663A9 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/24/2013 | US20130023558 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[4,5-c]PYRIDINE RING |
| 01/24/2013 | US20130023557 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
| 01/24/2013 | US20130023545 Cycloalkyloxycarboxylic acid derivatives |
| 01/24/2013 | US20130023544 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023500 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 01/24/2013 | CA2841102A1 Novel substituted indole derivatives as gamma secretase modulators |
| 01/24/2013 | CA2839743A1 Trpv4 antagonists |
| 01/23/2013 | EP2548258A1 Ionic liquids for batteries |
| 01/23/2013 | EP2547686A1 Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use |
| 01/23/2013 | EP2547685A1 Spiro-tetracyclic ring compounds as beta - secretase modulators |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892770A Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/23/2013 | CN102892767A Compounds for the treatment of hepatitis c |
| 01/23/2013 | CN102887905A Cis heterocyclic 1,2,3,4-tetrahydroisoquinoline derivatives and application thereof |
| 01/23/2013 | CN102887889A Heterocyclic substitute dpyrimidines |
| 01/23/2013 | CN101486715B Novel oxazine compound and use for preventing platelet aggregation |
| 01/22/2013 | US8357682 Gamma secretase modulators |
| 01/22/2013 | CA2667031C Hcv ns3 protease inhibitors |
| 01/17/2013 | WO2013009517A1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | US20130018202 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives |
| 01/17/2013 | US20130018185 Synthesis of 2,4-Pyrimidinediamines |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018046 Acetylenic Heteroaryl Compounds |
| 01/17/2013 | US20130018037 Compounds - 801 |
| 01/17/2013 | US20130018008 Crystalline forms of a macrolide, and uses therefor |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2840217A1 (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| 01/16/2013 | EP2546255A1 Benzazepine compound |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2545051A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | CN102875571A Latamoxef Sodium midbody synthetic method |
| 01/16/2013 | CN102875570A Quinazoline derivative, and preparation method and application thereof |
| 01/16/2013 | CN102875569A Isoxazole pyrimidone (or triazone) compounds with herbicidal activity and anti-liver cancer activity |
| 01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/15/2013 | US8354440 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/10/2013 | WO2013006485A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | WO2013006463A1 Oxazepines as ion channel modulators |
| 01/10/2013 | WO2013005755A1 Methylpiperidine derivative |
| 01/10/2013 | WO2013005354A1 Heterocyclic compound |
| 01/10/2013 | WO2013005057A1 New compounds |
| 01/10/2013 | WO2013005041A1 Tricyclic heterocyclic compounds as kinase inhibitors |
| 01/10/2013 | WO2013004984A1 Tricyclic compounds for use as kinase inhibitors |
| 01/10/2013 | WO2013004828A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | WO2013004827A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyridine ring |
| 01/10/2013 | WO2013004826A1 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
| 01/10/2013 | WO2013004824A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | WO2012096832A3 Hdac inhibiting derivatives of camptothecin |